An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead

M Valipour, H Irannejad, H Keyvani - ACS Pharmacology & …, 2023 - ACS Publications
The appearance of several coronavirus pandemics/epidemics during the last two decades
(SARS-CoV-1 in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019) indicates that …

Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic

R Bhandari, G Khanna, A Kuhad - European Journal of Pharmacology, 2021 - Elsevier
Coronaviruses are pleomorphic, enveloped, or spherical viruses, which have a size ranging
from 80 to 120 nm. These viruses act on receptors that cause the triggering of fusion …

[HTML][HTML] Progress in the research and development of anti-COVID-19 drugs

L Huang, Y Chen, J Xiao, W Luo, F Li, Y Wang… - Frontiers in public …, 2020 - frontiersin.org
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and
psychological damage to global human health. COVID-19 spread rapidly around the world …

An up-to-date overview of therapeutic agents for the treatment of COVID-19 disease

T Mulaw Belete - Clinical pharmacology: advances and …, 2020 - Taylor & Francis
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential to
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …

[HTML][HTML] The rationale for potential pharmacotherapy of COVID-19

M Saber-Ayad, MA Saleh, E Abu-Gharbieh - Pharmaceuticals, 2020 - mdpi.com
On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …

[HTML][HTML] An update on antiviral therapy against SARS-CoV-2: how far have we come?

O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …

[HTML][HTML] Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

Current scenario and future prospect in the management of COVID-19

P Borah, PK Deb, S Deka… - Current medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19

S Bhavaniramya, V Ramar… - Current Molecular …, 2022 - ingentaconnect.com
Corona viruses are enveloped, single-stranded RNA (Ribonucleic acid) viruses, and they
cause pandemic diseases having a devastating effect on both human healthcare and the …

[HTML][HTML] Drug targets for COVID-19 therapeutics: Ongoing global efforts

A Saxena - Journal of biosciences, 2020 - Springer
The current global pandemic COVID-19 caused by the SARS-CoV-2 virus has already
inflicted insurmountable damage both to the human lives and global economy. There is an …